Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (141c)tanzisertib
2. 4-(9-(tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9h-purin-2-ylamino)cyclohexanol
1. Cc-930
2. 899805-25-5
3. Tanzisertib [usan]
4. Cc 930
5. Chembl1950289
6. Jnk-930; Jnki-1
7. Jnk 930
8. Jnk-930
9. Cc930
10. M5o06306uo
11. Tanzisertib (usan)
12. (1s,4r)-4-((9-((s)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2-yl)amino)cyclohexanol
13. Trans-4-((9-((3s)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2-yl)amino)cyclohexanol
14. Cyclohexanol, 4-((9-((3s)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2-yl)amino)-, Trans-
15. Trans-4-({9-[(3s)-tetrahydrofuran-3-yl]-8-[(2,4,6-trifluorophenyl)amino]-9h-purin-2-yl}amino)cyclohexanol
16. Tanzisertib [usan:inn]
17. Unii-m5o06306uo
18. 3tti
19. Cc-930(tanzisertib)
20. Tanzisertib [inn]
21. Gtpl9836
22. Schembl2133055
23. Schembl2133061
24. Schembl4760419
25. Schembl8082102
26. Chembl1950305
27. Schembl10179476
28. Schembl15589918
29. Dtxsid601025671
30. Dtxsid901026042
31. Bcp16541
32. Ex-a3115
33. Bdbm50364378
34. Cc-930cc-930
35. Nsc800943
36. Zb1592
37. Zinc100285204
38. Zinc102930548
39. Compound 1 [pmid: 22244937]
40. Cs-1544
41. Db11798
42. Nsc-800943
43. Ncgc00378972-01
44. Ac-33706
45. Hy-15495
46. Trans-4-((9-((3s)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2- Yl)amino)cyclohexanol
47. C77038
48. D10168
49. A900102
50. Q21547222
51. 4-[[9-[(3s)-oxolan-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol
52. (1s,4r)-4-((9-((s)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2-yl)amino)cyclohexan-1-ol
53. 1629774-47-5
54. 4-[[9-[(3s)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9h-purin-2-yl]amino]cyclohexanol
55. Kbi
56. Trans-4-((9-((s)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9h-purin-2-yl)amino)cyclohexanol
57. Trans-4-(9-((s)-tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9h-purin-2-ylamino)cyclohexanol
| Molecular Weight | 448.4 g/mol |
|---|---|
| Molecular Formula | C21H23F3N6O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 5 |
| Exact Mass | 448.18345848 g/mol |
| Monoisotopic Mass | 448.18345848 g/mol |
| Topological Polar Surface Area | 97.1 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 618 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
70
PharmaCompass offers a list of Tanzisertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tanzisertib manufacturer or Tanzisertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tanzisertib manufacturer or Tanzisertib supplier.
PharmaCompass also assists you with knowing the Tanzisertib API Price utilized in the formulation of products. Tanzisertib API Price is not always fixed or binding as the Tanzisertib Price is obtained through a variety of data sources. The Tanzisertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tanzisertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tanzisertib, including repackagers and relabelers. The FDA regulates Tanzisertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tanzisertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tanzisertib supplier is an individual or a company that provides Tanzisertib active pharmaceutical ingredient (API) or Tanzisertib finished formulations upon request. The Tanzisertib suppliers may include Tanzisertib API manufacturers, exporters, distributors and traders.
Tanzisertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tanzisertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tanzisertib GMP manufacturer or Tanzisertib GMP API supplier for your needs.
A Tanzisertib CoA (Certificate of Analysis) is a formal document that attests to Tanzisertib's compliance with Tanzisertib specifications and serves as a tool for batch-level quality control.
Tanzisertib CoA mostly includes findings from lab analyses of a specific batch. For each Tanzisertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tanzisertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Tanzisertib EP), Tanzisertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tanzisertib USP).
